370 The Effects of Continuing Aspirin and Clopidogrel on Perioperative Outcomes in Primary Elective Total Knee and Hip Replacement: A Systematic Review and Meta-Analysis
British Journal of Surgery · 10.07.2026 · 113 (Supplement_6)
DOI: 10.1093/bjs/znag063.708 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift British Journal of Surgery, online erschienen am 10.07.2026. Verfasst von M Farhan-Alanie und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Aim
Approximately 20 % of patients undergoing primary elective total hip (THR) or knee replacement (TKR) take an antiplatelet medication. This is either continued or discontinued pre-operatively. Continuing antiplatelets may increase the risk of bleeding, wound complications, and infection. This systematic review and meta-analysis evaluated the effects of continuing aspirin or clopidogrel on perioperative outcomes of patients undergoing THR or TKR.
Method
Medline, Embase, Web of Science, and Cochrane Library were searched for randomised controlled trials and cohort studies reporting on outcomes blood loss, infection, wound complications, operative duration, length of stay, venous thromboembolism, cardiac and cerebrovascular events, mortality, and others. Random effects meta-analysis was performed.
Results
Eight studies enabled inclusion of data on 928 THRs and 3526 TKRs. Continuing antiplatelet therapy did not affect intraoperative blood loss in THR (MD -16.57 ml, 95 % CI -120.75–87.61, p = 0.76) or TKR (MD -0.06 ml, 95 %CI -6.04–5.91, p = 0.98). However, TKR patients continuing antiplatelet therapy had a higher risk of blood transfusion (OR 1.63, 95 %CI 1.25–2.13, p = 0.0003) although there were no differences observed in THR patients (OR 1.71, 95 %CI 0.84–3.49, p = 0.14). No significant differences were found for outcomes infection, cardiac and cerebrovascular events, and post-operative mortality between patient groups following THR and TKR.
Conclusions
Continuing antiplatelet use during TKR, but not THR, was associated with an increased risk of blood transfusion. Surgical complications and medical adverse events were not influenced by antiplatelet use. Further high-quality studies are needed to draw definitive conclusions.
Zitieren
APA
Farhan-Alanie, M., Hussein, A. A., Stephens, A., & Blankstein, M. (2026). 370 The Effects of Continuing Aspirin and Clopidogrel on Perioperative Outcomes in Primary Elective Total Knee and Hip Replacement: A Systematic Review and Meta-Analysis. British Journal of Surgery, 113(Supplement_6). https://doi.org/10.1093/bjs/znag063.708
Vancouver
Farhan-Alanie M, Hussein AA, Stephens A, Blankstein M. 370 The Effects of Continuing Aspirin and Clopidogrel on Perioperative Outcomes in Primary Elective Total Knee and Hip Replacement: A Systematic Review and Meta-Analysis. British Journal of Surgery. 2026;113(Supplement_6). doi:10.1093/bjs/znag063.708
BibTeX
@article{FarhanAlanie2026,
author = {Farhan-Alanie, M and Hussein, A Abdul and Stephens, A and Blankstein, M},
title = {370 The Effects of Continuing Aspirin and Clopidogrel on Perioperative Outcomes in Primary Elective Total Knee and Hip Replacement: A Systematic Review and Meta-Analysis},
journal = {British Journal of Surgery},
year = {2026},
volume = {113},
number = {Supplement_6},
doi = {10.1093/bjs/znag063.708}
}
EUVIMED